1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may link to a different grant program than the one shown here.
We recommend visiting the funder’s website directly to confirm this opportunity is available.
Search verified grants from National Institute on Aging (NIA) →Research Project Grant (Parent R01 Clinical Trial Required) is sponsored by National Institute on Aging (NIA). This is a broad funding opportunity for research projects, and the NIA supports and conducts research to understand the nature of aging and extend healthy, active years of life, including research on age-related diseases and conditions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers and institutions aligning with NIA's mission. Confirm the full requirements in the official notice before applying.
The published deadline was June 5, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Research Project Grant (Parent R01 Clinical Trial Required) is funded by National Institute on Aging (NIA). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Past winners and funding trends for this program
The National Institute on Aging's FY 2026 AD/ADRD portfolio consolidates the dementia research infrastructure layer — NCRAD, NACC, the new AI and Technology Collaboratory Coordinating Center — into a small number of large, often single-source cooperative agreements. The $113M new-research increment goes elsewhere. For investigators submitting in FY 2026, the structural change matters more than the headline dollar number.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article